Prices delayed by at least 15 minutes | Print
BIOMERIEUX (BIM)
BIOMERIEUXThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
BioMerieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (38% of 2021 sales), microbiology (31%), immunoassays (14%), and industrial applications (about 17%). The Americas account for the largest portion of the firm's revenue (49%), followed by Europe, the Middle East, and Africa (33%), and Asia-Pacific (18%). BioMerieux is headquartered in Marcy-l'Etoile, France.
Address
376, Chemin de l’Orme
Marcy l'Etoile
FRA
69280
Telephone
+33 478872237
Forecast key dates
Name | Key Date |
---|---|
BioMerieux SA Annual General Meeting for 2025 | 2025-05-23T00:00:00 |
BioMerieux SA Annual Report for 2024 | 2025-03-14T00:00:00 |
BioMerieux SA First Quarter Earnings Results for 2024 | 2025-03-14T00:00:00 |
BioMerieux SA Fourth Quarter Earnings Results for 2024 | 2025-03-14T00:00:00 |
BioMerieux SA First Quarter Earnings Conference Call for 2024 | 2025-03-14T00:00:00 |
BioMerieux SA Fourth Quarter Earnings Conference Call for 2024 | 2025-03-14T00:00:00 |
BioMerieux SA Second Quarter Earnings Conference Call for 2024 | 2024-09-05T00:00:00 |
BioMerieux SA Second Quarter Earnings Result for 2024 | 2024-09-05T00:00:00 |
BioMerieux SA Annual General Meeting for 2024 | 2024-05-23T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
BioMerieux SA Annual General Meeting for 2024 | 2024-05-23T00:00:00 |
BioMerieux SA Fourth Quarter Earnings Conference Call for 2023 | 2024-03-14T00:00:00 |
BioMerieux SA Fourth Quarter Earnings Result for 2023 | 2024-03-14T00:00:00 |
BioMerieux SA Second Quarter Earnings Conference Call for 2023 | 2023-09-01T00:00:00 |
BioMerieux SA Second Quarter Earnings Result for 2023 | 2023-09-01T00:00:00 |
BioMerieux SA Annual General Meeting for 2023 | 2023-05-23T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.